UTAH MEDICAL PRODUCTS INCUTMD決算レポート
Varian Medical Systems is an American radiation oncology treatments and software maker based in Palo Alto, California. Their medical devices include linear accelerators (LINACs) and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies software for managing cancer clinics, radiotherapy centers, and medical oncology practices. Varian Medical Systems employs more than 7,100 people at manufacturing sites...
UTMD Q4 2025 Key Financial Metrics
売上高
$9.0M
粗利益
$5.3M
営業利益
$2.4M
純利益
$2.6M
粗利益率
58.2%
営業利益率
27.0%
純利益率
28.4%
前年比成長
-1.2%
EPS
$0.80
資金フロー
UTAH MEDICAL PRODUCTS INC Q4 2025 財務サマリー
UTAH MEDICAL PRODUCTS INC reported revenue of $9.0M (down 1.2% YoY) for Q4 2025, with a net profit of $2.6M (down 11.6% YoY) (28.4% margin). Cost of goods sold was $3.8M, operating expenses totaled $2.8M.
主要財務指標
| 総売上高 | $9.0M |
|---|---|
| 純利益 | $2.6M |
| 粗利益率 | 58.2% |
| 営業利益率 | 27.0% |
| 報告期間 | Q4 2025 |
UTAH MEDICAL PRODUCTS INC 年度売上推移
UTAH MEDICAL PRODUCTS INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $38.5M). Click any linked year to see what changed vs the prior 10-K.
UTAH MEDICAL PRODUCTS INC 四半期売上・純利益の履歴
UTAH MEDICAL PRODUCTS INC quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| 四半期 | 売上高 | 売上前年比 | 純利益 | 純利益率 |
|---|---|---|---|---|
| Q4 2025 | $9.0M | -1.2% | $2.6M | 28.4% |
| Q3 2025 | $9.8M | -1.9% | $2.6M | 26.8% |
| Q2 2025 | $10.0M | -4.3% | $3.0M | 30.6% |
| Q1 2025 | $9.7M | -14.4% | $3.0M | 31.3% |
| Q4 2024 | $9.2M | -25.7% | $2.9M | 31.7% |
| Q3 2024 | $10.0M | -20.0% | $3.6M | 35.6% |
| Q2 2024 | $10.4M | -19.2% | $3.5M | 33.2% |
| Q1 2024 | $11.3M | -9.4% | $4.0M | 34.9% |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $11.3M | $10.4M | $10.0M | $9.2M | $9.7M | $10.0M | $9.8M | $9.0M |
| 前年比成長 | -9.4% | -19.2% | -20.0% | -25.7% | -14.4% | -4.3% | -1.9% | -1.2% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $135.4M | $130.0M | $129.7M | $122.5M | $122.5M | $120.8M | $122.0M | $122.5M |
| 総負債 | $7.7M | $6.0M | $5.5M | $5.1M | $5.5M | $3.3M | $3.7M | $3.3M |
| 株主資本 | $127.7M | $124.1M | $124.2M | $117.4M | $117.0M | $117.5M | $118.3M | $119.3M |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $5.3M | $2.8M | $3.9M | $2.9M | $4.5M | $2.9M | $3.9M | $3.5M |